The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
Background: Hemodialysis (HD) patients with functional iron deficiency often develop resistance to recombinant human erythropoietin (rhEPO). Recent studies have shown that intravenous ascorbic acid (IVAA) administration could override rhEPO resistance in HD patients. This study was undertaken to tes...
Main Authors: | Dae Woong Kang, Chi Yong Ahn, Bong Kwan Ryu, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2012-03-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211913212000113 |
Similar Items
-
Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hypeferritinemia
by: Shahrbanoo Keyhanian, et al.
Published: (2008-01-01) -
Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study
by: Ko‐Lin Kuo, et al.
Published: (2018-08-01) -
Evaluation of the management of anemia in hemodialysis patients in Lebanon
by: Marwan Akel, et al.
Published: (2017-04-01) -
Effects of Carnitine Supplement on Dyslipidemia and Anemia in Hemodialysis Patients
by: Afsoon Emami Naini, et al.
Published: (2011-07-01) -
Blood leptin levels and erythropoietin requirement in Iranian hemodialysis patients
by: Rahimi A, et al.
Published: (2008-12-01)